ATE182142T1 - Substituierte hydroxyacetyl piperazine phenyl oxazolidinonsäureester - Google Patents

Substituierte hydroxyacetyl piperazine phenyl oxazolidinonsäureester

Info

Publication number
ATE182142T1
ATE182142T1 AT94931278T AT94931278T ATE182142T1 AT E182142 T1 ATE182142 T1 AT E182142T1 AT 94931278 T AT94931278 T AT 94931278T AT 94931278 T AT94931278 T AT 94931278T AT E182142 T1 ATE182142 T1 AT E182142T1
Authority
AT
Austria
Prior art keywords
6alkyl
pct
date
substituted
acid esters
Prior art date
Application number
AT94931278T
Other languages
English (en)
Inventor
Steven J Brickner
Michel R Barbachyn
Douglas K Hutchinson
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of ATE182142T1 publication Critical patent/ATE182142T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT94931278T 1993-11-22 1994-09-27 Substituierte hydroxyacetyl piperazine phenyl oxazolidinonsäureester ATE182142T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15598893A 1993-11-22 1993-11-22

Publications (1)

Publication Number Publication Date
ATE182142T1 true ATE182142T1 (de) 1999-07-15

Family

ID=22557606

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94931278T ATE182142T1 (de) 1993-11-22 1994-09-27 Substituierte hydroxyacetyl piperazine phenyl oxazolidinonsäureester

Country Status (20)

Country Link
US (1) US5652238A (de)
EP (1) EP0730591B1 (de)
JP (1) JP3698724B2 (de)
KR (1) KR100312903B1 (de)
CN (1) CN1046276C (de)
AT (1) ATE182142T1 (de)
AU (1) AU698699B2 (de)
CA (1) CA2174107C (de)
CO (1) CO4290433A1 (de)
DE (1) DE69419523T2 (de)
DK (1) DK0730591T3 (de)
ES (1) ES2133588T3 (de)
GR (1) GR3031420T3 (de)
IL (1) IL111215A0 (de)
LV (1) LV12538B (de)
NZ (1) NZ274966A (de)
PE (1) PE22896A1 (de)
TW (1) TW427987B (de)
WO (1) WO1995014684A1 (de)
ZA (1) ZA947885B (de)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69529838T2 (de) * 1994-11-15 2003-11-13 Upjohn Co Antibakterielle bizyklische oxazin und thiazin-oxazolidinone
AU6964096A (en) * 1995-09-15 1997-04-01 Pharmacia & Upjohn Company Aminoaryl oxazolidinone n-oxides
ZA969622B (en) * 1995-12-13 1998-05-15 Upjohn Co Oxazolidinone antibacterial agents having a six-membered heteroaromatic ring.
GB9601666D0 (en) * 1996-01-27 1996-03-27 Zeneca Ltd Chemical compounds
GB9702213D0 (en) 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds
MY116093A (en) * 1996-02-26 2003-11-28 Upjohn Co Azolyl piperazinyl phenyl oxazolidinone antimicrobials
GB9609919D0 (en) 1996-05-11 1996-07-17 Zeneca Ltd Chemical compounds
GB9614238D0 (en) * 1996-07-06 1996-09-04 Zeneca Ltd Chemical compounds
GB9614236D0 (en) * 1996-07-06 1996-09-04 Zeneca Ltd Chemical compounds
GB9717804D0 (en) 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
GB9717807D0 (en) 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
US5998406A (en) * 1997-11-12 1999-12-07 Pharmacia & Upjohn Company Oxazolidinone derivatives and pharmaceutical compositions
US6040306A (en) * 1997-11-18 2000-03-21 Pharmacia & Upjohn Company Method of treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy
ATE299021T1 (de) * 1997-11-18 2005-07-15 Pharmacia & Upjohn Co Llc Verwendung von oxazolidinonderivaten zur behandlung von psoriasis
EP1032386B1 (de) * 1997-11-18 2003-02-26 PHARMACIA & UPJOHN COMPANY Verwendung von oxazolidinonderivate zur behandlung von arthritis
AU780197B2 (en) * 1997-11-18 2005-03-10 Pharmacia & Upjohn Company Method of treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy
GB9725244D0 (en) 1997-11-29 1998-01-28 Zeneca Ltd Chemical compounds
US7002020B1 (en) 1998-01-23 2006-02-21 Pharmacia & Upjohn Company Oxazolidinone combinatorial libraries, compositions and methods of preparation
US6562844B2 (en) 1998-01-23 2003-05-13 Pharmacia & Upjohn Company Oxazolidinone combinatorial libraries, compositions and methods of preparation
AU764184B2 (en) * 1998-01-23 2003-08-14 Pharmacia & Upjohn Company Oxazolidinone combinatorial libraries, compositions and methods of preparation
WO1999041244A1 (en) * 1998-02-13 1999-08-19 Pharmacia & Upjohn Company Substituted aminophenyl isoxazoline derivatives useful as antimicrobials
PL345162A1 (en) 1998-06-05 2001-12-03 Astrazeneca Ab Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
MY122454A (en) * 1998-06-05 2006-04-29 Upjohn Co Use of oxazolidinones for the preparation of a medicament for transdermal delivery
CN1305374A (zh) 1998-07-14 2001-07-25 法玛西雅厄普约翰美国公司 治疗眼部感染的噁唑烷酮
AR020660A1 (es) * 1998-09-30 2002-05-22 Alcon Lab Inc Composiciones antibioticas para el tratamiento de ojos, oidos y nariz
JP2002535680A (ja) 1999-01-27 2002-10-22 ファルマシア・アンド・アップジョン・カンパニー 延長因子p活性モジュレーターのアッセイ方法
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
PE20010851A1 (es) * 1999-12-14 2001-08-17 Upjohn Co Esteres del acido benzoico de oxazolidinonas que tienen un substituyente hidroxiacetilpiperazina
US6642238B2 (en) 2000-02-10 2003-11-04 Pharmacia And Upjohn Company Oxazolidinone thioamides with piperazine amide substituents
GB0009803D0 (en) * 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
EP1289984A4 (de) * 2000-06-05 2004-11-24 Dong A Pharm Co Ltd Neue oxazolidinderivate und ein verfahren zu ihrer herstellung
SK1402003A3 (en) * 2000-07-17 2003-08-05 Ranbaxy Lab Ltd Oxazolidinone derivatives as antimicrobials
PE20020300A1 (es) * 2000-08-22 2002-05-10 Pharmacia Corp Composicion de solucion de un farmaco antibiotico a base de oxazolidinona con mejoramiento de la carga de farmaco
AR031135A1 (es) 2000-10-10 2003-09-10 Upjohn Co Composiciones de antibiotico topico para el tratamiento de infecciones oculares
US6861433B2 (en) * 2000-12-15 2005-03-01 Pharmacia & Upjohn Company Oxazolidinone photoaffinity probes
US6956040B2 (en) 2001-07-16 2005-10-18 Ranbaxy Laboratories Limited Oxazolidinone piperazinyl derivatives as potential antimicrobials
EP1409464A4 (de) * 2001-07-16 2005-11-02 Ranbaxy Lab Ltd Oxazolidinonderivate als potentielle antimikrobielle mittel
TW200302095A (en) * 2002-01-25 2003-08-01 Upjohn Co Oxazolidinone cotherapy
AR038576A1 (es) * 2002-02-22 2005-01-19 Pharmacia Corp Formulaciones de drogas antibioticas oftalmicas que contienen un compuesto de ciclodextrina y cloruro de cetil piridinio
US7141588B2 (en) * 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
AR038536A1 (es) * 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
IL164195A0 (en) * 2002-03-29 2005-12-18 Upjohn Co Parenteral, intravenous, and oral administration of oxazolidinones for treating diabetic foot infections
US7094900B2 (en) * 2002-08-12 2006-08-22 Pharmacia & Upjohn Company Llc N-Aryl-2-oxazolidinones and their derivatives
CA2513416A1 (en) * 2002-08-22 2004-03-04 Orchid Chemicals & Pharmaceuticals Ltd. Novel antibacterial agents
AU2002339721A1 (en) * 2002-09-20 2004-04-08 Lupin Limited Oxazolidinone derivatives, process for their preperation and their use as antimycobacterial agents
AU2003280143A1 (en) 2002-11-21 2004-06-15 Pharmacia & Upjohn Company Llc N-(4-(piperazin-1-yl)-phenyl-2-oxazolidinone-5-carboxamide derivates and related compounds as antibacterial agents
WO2004058732A1 (fr) * 2002-12-30 2004-07-15 Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences Derive d'oxazolidine, technique de preparation et d'utilisations
US20040170686A1 (en) * 2003-01-31 2004-09-02 Fredrickson Jennifer K. Suspension vehicle for coated drug particles
MXPA05007724A (es) * 2003-02-07 2005-09-30 Warner Lambert Co Agentes antibacterianos.
MXPA05007937A (es) * 2003-02-07 2005-09-30 Warner Lambert Co Agentes antibacterianos.
US20040191326A1 (en) * 2003-03-31 2004-09-30 Reo Joseph P. Taste-masking vehicle for coated oxazolidinone particles
US20040204463A1 (en) * 2003-04-01 2004-10-14 Harris Christina Renee N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
WO2005019214A1 (en) * 2003-08-25 2005-03-03 Warner-Lambert Company Llc Novel antimicrobial aryloxazolidinone compounds
US7304050B2 (en) * 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
KR100854211B1 (ko) 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
EP1925609A1 (de) * 2006-11-23 2008-05-28 Agfa Graphics N.V. Neue Coinitiatoren
WO2008061954A1 (en) * 2006-11-23 2008-05-29 Agfa Graphics Nv Novel co-initiators
KR101023174B1 (ko) * 2008-09-24 2011-03-18 주식회사 레고켐 바이오사이언스 사이클릭 아미독심 또는 사이클릭 아미드라존 기를 가지는 신규한 옥사졸리디논 유도체 및 이를 함유하는 의약 조성물
MX2011003820A (es) * 2008-10-10 2011-06-16 Trius Therapeutics Metodos para preparar oxazolidinonas y composiciones que las contienen.
SG10201500207QA (en) 2009-02-03 2015-03-30 Merck Sharp & Dohme Crystalline form of r)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate
EP2406239B1 (de) * 2009-03-13 2016-09-14 Sun Chemical B.V. Für energiehärtbare zusammensetzungen geeignete cyclische carbamatverbindungen
US8580767B2 (en) * 2009-05-28 2013-11-12 Trius Therapeutics, Inc. Oxazolidinone containing dimer compounds, compositions and methods to make and use

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801600A (en) * 1987-10-09 1989-01-31 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
US4921869A (en) * 1987-10-09 1990-05-01 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
CA1320730C (en) * 1987-10-16 1993-07-27 The Du Pont Merck Pharmaceutical Company Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents
ATE95176T1 (de) * 1987-10-21 1993-10-15 Du Pont Merck Pharma Aminomethyl-oxo-oxazolidinyl-ethenylbenzenderivate, nuetzlich als antibakterielles mittel.
US4948801A (en) * 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
US5182403A (en) * 1988-09-15 1993-01-26 The Upjohn Company Substituted 3(5'indazolyl) oxazolidin-2-ones
US5225565A (en) * 1988-09-15 1993-07-06 The Upjohn Company Antibacterial 3-(fused-ring substituted)phenyl-5β-amidomethyloxazolidin-2-ones
US5164510A (en) * 1988-09-15 1992-11-17 The Upjohn Company 5'Indolinyl-5β-amidomethyloxazolidin-2-ones
AU667198B2 (en) * 1991-11-01 1996-03-14 Pharmacia & Upjohn Company Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny

Also Published As

Publication number Publication date
CN1135752A (zh) 1996-11-13
JP3698724B2 (ja) 2005-09-21
CO4290433A1 (es) 1996-04-17
AU8010394A (en) 1995-06-13
NZ274966A (en) 1998-01-26
KR100312903B1 (ko) 2002-02-28
ES2133588T3 (es) 1999-09-16
CA2174107A1 (en) 1995-06-01
AU698699B2 (en) 1998-11-05
EP0730591A1 (de) 1996-09-11
WO1995014684A1 (en) 1995-06-01
LV12538A (en) 2000-10-20
GR3031420T3 (en) 2000-01-31
DK0730591T3 (da) 2000-01-31
PE22896A1 (es) 1996-06-07
CA2174107C (en) 2005-04-12
ZA947885B (en) 1996-04-09
IL111215A0 (en) 1994-12-29
CN1046276C (zh) 1999-11-10
DE69419523D1 (en) 1999-08-19
EP0730591B1 (de) 1999-07-14
KR960705818A (ko) 1996-11-08
LV12538B (en) 2000-12-20
DE69419523T2 (de) 1999-11-25
TW427987B (en) 2001-04-01
US5652238A (en) 1997-07-29
JPH09505582A (ja) 1997-06-03

Similar Documents

Publication Publication Date Title
ATE182142T1 (de) Substituierte hydroxyacetyl piperazine phenyl oxazolidinonsäureester
HUT77602A (hu) Mikrobicid hatású fenil-oxazolidinon-származékok és alkalmazásuk gyógyszerkészítmények előállítására
NZ295528A (en) Bicyclic oxazine and thiazine oxazolidinone antibacterials
BG105271A (en) 1h-imidazopyridine derivatives
MY115155A (en) Substituted oxazine and thiazine oxazolidinone antimicrobials.
DK0874852T3 (da) Antibakterielt oxazolidinonmiddel med tricykliske substituenter
MX9703040A (es) Antimicrobianos de feniloxazolidinona.
GR3025116T3 (en) Process for the preparation of n-carbonylarylimines useful for the synthesis of therapeutically active taxoids
TH77466EX (th) สารต่อต้านการเจริญเติบโตของจุลินทรีย์ที่เป็นซับสทิทิวเทดออกซาซีน และไธแอซีนออกซาโซลิดิโนน
TH16642A (th) สารต่อต้านการเจริญเติบโตของจุลินทรีย์ที่เป็นซับสทิทิวเทดออกซาซีนและไธแอซีนออกซาโซลิดิโนน
TH77466A (th) สารต่อต้านการเจริญเติบโตของจุลินทรีย์ที่เป็นซับสทิทิวเทดออกซาซีน และไธแอซีนออกซาโซลิดิโนน

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee